U.S. pharma huge copyright scrapped two experimental weight loss supplements last yr—a after-every day pill, lotiglipron, because of elevated liver enzymes plus a two times-daily tablet, danuglipron, on account of strong Negative effects—but CEO Albert Bourla has explained the compan